{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:40:00Z","timestamp":1776300000141,"version":"3.50.1"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2014,7,31]],"date-time":"2014-07-31T00:00:00Z","timestamp":1406764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0103915","type":"journal-article","created":{"date-parts":[[2014,7,31]],"date-time":"2014-07-31T21:11:51Z","timestamp":1406841111000},"page":"e103915","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Inhibition of Euchromatic Histone Methyltransferase 1 and 2 Sensitizes Chronic Myeloid Leukemia Cells to Interferon Treatment"],"prefix":"10.1371","volume":"9","author":[{"given":"Sheng Wei","family":"Loh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei Lun","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kok Siong","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yat-Yuen","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chee-Kwee","family":"Ea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,7,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"LC Platanias","year":"2005","journal-title":"Nature reviews Immunology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining","volume":"243","author":"JD Rowley","year":"1973","journal-title":"Nature"},{"key":"ref3","first-page":"299","article-title":"Interferons: biochemical, cell growth inhibitory, and immunological effects","volume":"12","author":"EC Borden","year":"1981","journal-title":"Progress in hematology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"31207","DOI":"10.1074\/jbc.M112.365601","article-title":"EHMT1 protein binds to nuclear factor-kappaB p50 and represses gene expression","volume":"287","author":"CK Ea","year":"2012","journal-title":"The Journal of biological chemistry"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1084\/jem.20112343","article-title":"Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response","volume":"209","author":"TC Fang","year":"2012","journal-title":"The Journal of experimental medicine"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.molcel.2007.01.017","article-title":"Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase","volume":"25","author":"S Kubicek","year":"2007","journal-title":"Mol Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/stem.5530010205","article-title":"Establishment of a Ph1 chromosome-positive cell line from chronic myelogenous leukemia in blast crisis","volume":"1","author":"I Kubonishi","year":"1983","journal-title":"Int J Cell Cloning"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1182\/blood.V91.2.641","article-title":"Suppression of cell proliferation and the expression of a bcr-abl fusion gene and apoptotic cell death in a new human chronic myelogenous leukemia cell line, KT-1, by interferon-alpha","volume":"91","author":"K Yanagisawa","year":"1998","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e75517","DOI":"10.1371\/journal.pone.0075517","article-title":"Identification of an enhancer that increases miR-200b\u223c200a\u223c429 gene expression in breast cancer cells","volume":"8","author":"JL Attema","year":"2013","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nchembio.599","article-title":"A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells","volume":"7","author":"M Vedadi","year":"2011","journal-title":"Nature chemical biology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.beha.2009.10.005","article-title":"Interferon in chronic myeloid leukaemia: past and future","volume":"22","author":"F Guilhot","year":"2009","journal-title":"Best practice & research Clinical haematology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1182\/blood.V80.3.744.744","article-title":"Correlation between interferon (IFN) alpha resistance and deletion of the IFN alpha\/beta genes in acute leukemia cell lines suggests selection against the IFN system","volume":"80","author":"OR Colamonici","year":"1992","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1182\/blood-2002-01-0073","article-title":"Constitutive expression of SOCS3 confers resistance to IFN-alpha in chronic myelogenous leukemia cells","volume":"100","author":"I Sakai","year":"2002","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1101\/gad.1284005","article-title":"Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9","volume":"19","author":"M Tachibana","year":"2005","journal-title":"Genes Dev"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.2408149","article-title":"Tyrosine kinase activity and transformation potency of bcr-abl oncogene products","volume":"247","author":"T Lugo","year":"1990","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ajh.21380","article-title":"First-line therapy for chronic myeloid leukemia: Past, present, and future","volume":"84","author":"C Pavlovsky","year":"2009","journal-title":"American journal of hematology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/leu.2009.38","article-title":"Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia","volume":"23","author":"A Hochhaus","year":"2009","journal-title":"Leukemia"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.2146\/ajhp070482","article-title":"Targeted chronic myeloid leukemia therapy: Seeking a cure","volume":"64","author":"C Fausel","year":"2007","journal-title":"American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/leu.2012.313","article-title":"Re-emergence of interferon-alpha in the treatment of chronic myeloid leukemia","volume":"27","author":"M Talpaz","year":"2013","journal-title":"Leukemia"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0300-483X(99)00141-9","article-title":"Endocrine and neurological adverse effects of the therapeutic interferons","volume":"142","author":"T Vial","year":"2000","journal-title":"Toxicology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(01)00542-6","article-title":"Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability","volume":"107","author":"AH Peters","year":"2001","journal-title":"Cell"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1101\/gad.989402","article-title":"G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis","volume":"16","author":"M Tachibana","year":"2002","journal-title":"Genes Dev"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0103915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T20:28:49Z","timestamp":1598128129000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0103915"}},"subtitle":[],"editor":[{"given":"Axel","family":"Imhof","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,31]]},"references-count":22,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0103915","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,31]]}}}